Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-U3319
Molecular Cytogenetics Market Overview: FutureWise Market Research has instantiated a report that provides an intricate analysis of Molecular Cytogenetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Molecular Cytogenetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. The increasing prevalence of genetic disorders, improving healthcare infrastructure, increased adoption of molecular cytogenic products in research and clinical laboratories, pharmaceutical and biotech companies and academic institutes and increased emphasis on targeted treatment of cancer are some of the crucial factors responsible for the growth of the market. The cytogenic analysis earlier focused only on investigating the cellular aspects that detected the genomic aberrations and studying the structure of chromosome in heredity conditions. Currently, cytogenic analysis is being extensively used for applications others than identifying a genome’s chromosomal status, which has enhanced the study of changes in the chromosome involved in the pathogenesis of a disease, the human genome organization in three dimensions. Human genetics is prominently used for bridging the gap between the provisions of a refined medical service and the applications of findings of genes. Such a broad range of applications shall augment the market growth. Additionally, the rising prevalence of cancer and increased mortality rate annually has substantially helped in the molecular cytogenetics market growth. Such a consistent rise in new cancer cases has increased the necessity for developing novel technologies for a completer understanding of cancer genomically. Some of the recognised cytogenic methods like Comparative Genomic Hybridization and FISH that offer extensive insights about the molecular signatures related to cancer, thereby gaining information on the progression of cancer. Increased pharmacogenomic activities are predicted to substantially influence the proliferation of the market. However, the reimbursement policies for molecular cytogenetics are unfavourable and these instruments being expensive, the treatments are meant to be expensive as well, thereby negatively affecting the growth of the market. Major players included in the Molecular Cytogenetics Market: • F. Hoffmann-La Roche Ltd. • Danaher Corporation • Thermo Fisher Scientific, Inc. • Abbott Laboratories • Agilent Technologies • PerkinElmer, Inc. • Illumina, Inc. • Bio-Rad Laboratories • Oxford Gene Technology • Applied Spectral Imaging (Note: The list of the major players will be updated with the latest market scenario and trends) Market Segmentation: By Product • Kits & Reagents o Testing Kits o Probes o Fluorescent Affinity Reagents o Other Kits & Reagents • Instruments • Consumables • Software & Services By Technique • Comparative Genomic Hybridization o Array-Based Comparative Genomic Hybridization o Standard Comparative Genomic Hybridization • Fluorescence in Situ Hybridization • In Situ Hybridization • Other Techniques By Application • Genetic Disorders • Cancer • Personalized Medicine • Other Applications By End User • Clinical & Research Laboratories • Academic Research Institutes • Pharmaceutical and Biotechnology Companies • Other End Users By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Regional Analysis: The North America region is predicted to lead the global market owing to a strong presence of major market players, implementation of an efficient regulatory framework for regulating genetic tests. The Asia Pacific region, however, is anticipated to grow at a significant rate during the forecast period. This is mainly due to the consistent rise in the gross domestic product of nations like India, Japan which shall enhance the buying drive and power of the consumer. Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global molecular cytogenetics market By Product, By Technique, By Application, By End User and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Molecular Cytogenetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Molecular Cytogenetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
The increasing prevalence of genetic disorders, improving healthcare infrastructure, increased adoption of molecular cytogenic products in research and clinical laboratories, pharmaceutical and biotech companies and academic institutes and increased emphasis on targeted treatment of cancer are some of the crucial factors responsible for the growth of the market. The cytogenic analysis earlier focused only on investigating the cellular aspects that detected the genomic aberrations and studying the structure of chromosome in heredity conditions. Currently, cytogenic analysis is being extensively used for applications others than identifying a genome’s chromosomal status, which has enhanced the study of changes in the chromosome involved in the pathogenesis of a disease, the human genome organization in three dimensions. Human genetics is prominently used for bridging the gap between the provisions of a refined medical service and the applications of findings of genes. Such a broad range of applications shall augment the market growth. Additionally, the rising prevalence of cancer and increased mortality rate annually has substantially helped in the molecular cytogenetics market growth. Such a consistent rise in new cancer cases has increased the necessity for developing novel technologies for a completer understanding of cancer genomically. Some of the recognised cytogenic methods like Comparative Genomic Hybridization and FISH that offer extensive insights about the molecular signatures related to cancer, thereby gaining information on the progression of cancer. Increased pharmacogenomic activities are predicted to substantially influence the proliferation of the market. However, the reimbursement policies for molecular cytogenetics are unfavourable and these instruments being expensive, the treatments are meant to be expensive as well, thereby negatively affecting the growth of the market.
Major players included in the Molecular Cytogenetics Market: • F. Hoffmann-La Roche Ltd. • Danaher Corporation • Thermo Fisher Scientific, Inc. • Abbott Laboratories • Agilent Technologies • PerkinElmer, Inc. • Illumina, Inc. • Bio-Rad Laboratories • Oxford Gene Technology • Applied Spectral Imaging (Note: The list of the major players will be updated with the latest market scenario and trends)
Market Segmentation:
By Product • Kits & Reagents o Testing Kits o Probes o Fluorescent Affinity Reagents o Other Kits & Reagents • Instruments • Consumables • Software & Services
By Technique • Comparative Genomic Hybridization o Array-Based Comparative Genomic Hybridization o Standard Comparative Genomic Hybridization • Fluorescence in Situ Hybridization • In Situ Hybridization • Other Techniques
By Application • Genetic Disorders • Cancer • Personalized Medicine • Other Applications
By End User • Clinical & Research Laboratories • Academic Research Institutes • Pharmaceutical and Biotechnology Companies • Other End Users
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Regional Analysis:
The North America region is predicted to lead the global market owing to a strong presence of major market players, implementation of an efficient regulatory framework for regulating genetic tests. The Asia Pacific region, however, is anticipated to grow at a significant rate during the forecast period. This is mainly due to the consistent rise in the gross domestic product of nations like India, Japan which shall enhance the buying drive and power of the consumer.
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global molecular cytogenetics market By Product, By Technique, By Application, By End User and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Molecular Cytogenetics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Molecular Cytogenetics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Molecular Cytogenetics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Molecular Cytogenetics Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Kits & Reagents 7.1.1. Testing Kits 7.1.2. Probes 7.1.3. Fluorescent Affinity Reagents 7.1.4. Other Kits & Reagents 7.2. Instruments 7.3. Consumables 7.4. Software & Services 8. Molecular Cytogenetics Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Comparative Genomic Hybridization 8.1.1. Array-Based Comparative Genomic Hybridization 8.1.2. Standard Comparative Genomic Hybridization 8.2. Fluorescence in Situ Hybridization 8.3. In Situ Hybridization 8.4. Other Techniques 9. Molecular Cytogenetics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Genetic Disorders 9.2. Cancer 9.3. Personalized Medicine 9.4. Other Applications 10. Molecular Cytogenetics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Clinical & Research Laboratories 10.2. Academic Research Institutes 10.3. Pharmaceutical and Biotechnology Companies 10.4. Other End Users 11. North America Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. F. Hoffmann-La Roche Ltd. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Danaher Corporation 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Thermo Fisher Scientific, Inc. 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Abbott Laboratories 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Agilent Technologies 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. PerkinElmer, Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Illumina, Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Bio-Rad Laboratories 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Oxford Gene Technology 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Applied Spectral Imaging 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Molecular Cytogenetics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Molecular Cytogenetics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Molecular Cytogenetics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Molecular Cytogenetics Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Kits & Reagents 7.1.1. Testing Kits 7.1.2. Probes 7.1.3. Fluorescent Affinity Reagents 7.1.4. Other Kits & Reagents 7.2. Instruments 7.3. Consumables 7.4. Software & Services
8. Molecular Cytogenetics Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Comparative Genomic Hybridization 8.1.1. Array-Based Comparative Genomic Hybridization 8.1.2. Standard Comparative Genomic Hybridization 8.2. Fluorescence in Situ Hybridization 8.3. In Situ Hybridization 8.4. Other Techniques
9. Molecular Cytogenetics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Genetic Disorders 9.2. Cancer 9.3. Personalized Medicine 9.4. Other Applications
10. Molecular Cytogenetics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Clinical & Research Laboratories 10.2. Academic Research Institutes 10.3. Pharmaceutical and Biotechnology Companies 10.4. Other End Users
11. North America Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Molecular Cytogenetics Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. F. Hoffmann-La Roche Ltd. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Danaher Corporation 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Thermo Fisher Scientific, Inc. 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Abbott Laboratories 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Agilent Technologies 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. PerkinElmer, Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Illumina, Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Bio-Rad Laboratories 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Oxford Gene Technology 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Applied Spectral Imaging 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics